BlackRock Health Sciences Trust
US ˙ NYSE ˙ US09250W1071

SecurityBME / BlackRock Health Sciences Trust
InstitutionNova R Wealth, Inc.
Latest Disclosed Ownership582,784 shares
Ownership 5.37%
Nova R Wealth, Inc. ownership in BME / BlackRock Health Sciences Trust

2020-02-05 - Nova R Wealth, Inc. has filed an SC 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 582,784 shares of BlackRock Health Sciences Trust (US:BME). This represents 5.37 percent ownership of the company.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2020-02-05 2020-02-05 13G 582,784 5.37
2019-01-18 2019-01-18 13G/A 601,577
2018-02-06 2018-02-06 13G

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-17 2026-03-31 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 154,617 -76,069 -32.98 5,954 -37.25 1.8998
2026-01-14 2025-12-31 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 230,686 -23,039 -9.08 9,488 0.44 3.4588
2025-10-23 2025-09-30 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 253,725 -27,624 -9.82 9,446 -7.91 4.0051
2025-07-17 2025-06-30 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 281,349 -32,497 -10.35 10,258 -15.42 4.7690
2025-04-23 2025-03-31 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 313,846 -6,396 -2.00 12,127 -0.16 6.0065
2025-01-30 2024-12-31 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 320,242 -12,727 -3.82 12,147 -13.00 6.1236
2024-10-15 2024-09-30 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 332,969 -6,863 -2.02 13,961 0.57 6.8745
2024-07-18 2024-06-30 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 339,832 -18,037 -5.04 13,882 -6.39 7.1562
2024-04-12 2024-03-31 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 357,869 -19,897 -5.27 14,830 -2.97 7.7429
2024-01-19 2023-12-31 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 377,766 -22,610 -5.65 15,284 -2.49 9.6264
2023-10-19 2023-09-30 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 400,376 -10,360 -2.52 15,675 -6.10 10.8204
2023-07-27 2023-06-30 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 410,736 -44,322 -9.74 16,692 -12.37 11.1837
2023-04-17 2023-03-31 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 455,058 1,133 0.25 19,049 -3.71 12.8830
2023-01-31 2022-12-31 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 453,925 -11,097 -2.39 19,782 9.58 14.4844
2022-10-25 2022-09-30 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 465,022 -7,425 -1.57 18,052 -9.88 14.7060
2022-07-15 2022-06-30 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 472,447 -24,590 -4.95 20,032 -11.46 16.4784
2022-05-10 2022-03-31 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 497,037 -30,705 -5.82 22,625 -11.61 19.3267
2022-01-27 2021-12-31 13F BLACKROCK HEALTH SCIENCES TR COM 09250W107 527,742 527,742 25,596 20.6992
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.